This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 7-10, 2023 | In-Person + Digital
San Diego, CA, USAManchester Grand Hyatt San Diego

Glenn Milton, PhD
Analytical Development Scientist at Moderna


Glenn Milton completed his undergraduate studies with a B.S. from Quinnipiac University in 2010. He completed his Ph.D. in Molecular and Cell Biology (Genetics and Genomics) from the University of Connecticut in 2018 where he studied imprinted genes on the X chromosome. In 2021 Glenn Milton joined Moderna Tx as a Scientist in Analytical Development as a subject matter expert on NGS technologies. He is also leading mRNA characterization in Analytical Development across many programs.

Agenda Sessions

  • mRNA Characterization in Analytical Development